» Authors » Christelle Gateau

Christelle Gateau

Explore the profile of Christelle Gateau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Szekeres L, Maldivi P, Lebrun C, Gateau C, Mesterhazy E, Delangle P, et al.
Inorg Chem . 2023 Apr; 62(17):6817-6824. PMID: 37071818
The As binding of two NTA-based tripodal pseudopeptides, possessing three cysteine (ligand ) or d-penicillamine residues (ligand ) as potential coordinating groups for soft semimetals or metal ions, was studied...
2.
Laporte F, Chenavier Y, Botz A, Gateau C, Lebrun C, Hostachy S, et al.
Angew Chem Int Ed Engl . 2022 Apr; 61(26):e202203198. PMID: 35466512
Determining the affinity of proteins for uranyl is key to understand the toxicity of this cation and to further develop decorporation strategies. However, usual techniques to achieve that goal often...
3.
Gauthier L, Charbonnier P, Chevallet M, Delangle P, Texier I, Gateau C, et al.
Int J Pharm . 2021 Oct; 609:121193. PMID: 34673167
Copper homeostasis is finely regulated in human to avoid any detrimental impact of free intracellular copper ions. Upon copper accumulation, biliary excretion is triggered in liver thanks to trafficking of...
4.
Das R, Claron M, Lebrun C, Pecaut J, Ambala S, Gateau C, et al.
J Inorg Biochem . 2021 Jun; 222:111518. PMID: 34182264
Imidazole thiones appear as interesting building blocks for Cu(I) chelation and protection against Cu-mediated oxidative stress. Therefore, a series of tripodal molecules derived from nitrilotriacetic acid appended with three imidazole...
5.
Gauthier L, Chevallet M, Bulteau F, Thepaut M, Delangle P, Fieschi F, et al.
J Drug Target . 2020 Sep; 29(1):99-107. PMID: 32936032
Liver is the main organ for metabolism but is also subject to various pathologies, from viral, genetic, cancer or metabolic origin. There is thus a crucial need to develop efficient...
6.
Monestier M, Pujol A, Lamboux A, Cuillel M, Pignot-Paintrand I, Cassio D, et al.
Metallomics . 2020 May; 12(6):1000-1008. PMID: 32401247
Copper chelation is the most commonly used therapeutic strategy nowadays to treat Wilson's disease, a genetic disorder primarily inducing a pathological accumulation of Cu in the liver. The mechanism of...
7.
Van der Meeren A, Lemaire D, Coudert S, Drouet G, Benameur M, Gouzerh C, et al.
Toxicol In Vitro . 2020 Apr; 66:104863. PMID: 32304792
Inhalation of CoO particles may occur at the work place in nuclear industry. Their low solubility may result in chronic lung exposure to γ rays. Our strategy for an improved...
8.
Marchioni M, Veronesi G, Worms I, Ling W, Gallon T, Leonard D, et al.
Nanoscale Horiz . 2020 Mar; 5(3):507-513. PMID: 32118225
Silver nanoparticles (AgNPs) are efficient biocides increasingly used in consumer products and medical devices. Their activity is due to their capacity to release bioavailable Ag(i) ions making them long-lasting biocides...
9.
Gauthier L, Varache M, Couffin A, Lebrun C, Delangle P, Gateau C, et al.
Int J Mol Sci . 2019 Nov; 20(22). PMID: 31726778
Nanoparticles have been extensively studied for drug delivery and targeting to specific organs. The functionalization of the nanoparticle surface by site-specific ligands (antibodies, peptides, saccharides) can ensure efficient recognition and...
10.
Domergue J, Pecaut J, Proux O, Lebrun C, Gateau C, Le Goff A, et al.
Inorg Chem . 2019 Sep; 58(19):12775-12785. PMID: 31545024
The superoxide dismutase (SOD) activity of mononuclear Ni complexes, whose structures are inspired by the NiSOD, has been investigated. They have been designed with a sulfur-rich pseudopeptide ligand, derived from...